Results 51 to 60 of about 10,137 (203)

Cardiorenal relationships in patients with chronic heart failure with preserved ejection fraction

Лечащий Врач, 2023
The combination of heart and kidney diseases caused by chronic heart failure and aggravated by kidney damage, called cardiorenal syndrome, is increasingly recognized as a critical pathological unit, leading to a worsening of the prognosis in patients ...
Yu. N. Panina, V. I. Vishnevsky
doaj   +1 more source

A phenomap of TTR amyloidosis to aid diagnostic screening

ESC Heart Failure, Volume 12, Issue 2, Page 1113-1118, April 2025.
Abstract Cardiac amyloidosis due to transthyretin (ATTR) remains an underdiagnosed cause of cardiomyopathy. As awareness of the disease grows and referrals for ATTR increase, clinicians are likely to encounter more atypical forms of the condition in clinical practice.
Alexios S. Antonopoulos, Theodoros Tsampras, George Lazaros, Konstantinos Tsioufis, Charalambos Vlachopoulos   +4 more
wiley   +1 more source

Cardiorenal syndrome – a review [PDF]

, 2016
IP USMF „Nicolae Testemiţanu”, Disciplina Cardiologie, Departamentul Medicină Internă, IP USMF „Nicolae Testemiţanu”, Disciplina Reumatologie și Nefrologie, Departamentul Medicină InternăCoexistența insuficienței cardiace și renale în dezvoltarea ...
Grib, Liviu, Bivol, Elena, Sasu, Boris
core  

Beyond Traditional Screening: The Future of Heart Failure Detection With Biomarkers and AI

iNew Medicine, EarlyView.
Advancing HF Screening: Integrating Technology and Risk Factors Across Eras. This diagram provides a comprehensive review of the historical developments and projected trends of heart failure (HF) screening methodologies, with the prevalent risk factors for HF depicted at the base.
Xiaofeng Fang, Yinbo Xu, Yiting Zhao, Liuyi Li, Zhengyi Cheng, Zhongqi Zhang, Yuhang Luo, Qiaoling Liu, Chen Gong, Shichun Shen   +9 more
wiley   +1 more source

Serum NT-pro BNP and Other Biochemical Markers in Patients with Cardiorenal Syndrome (CRS) in Thi- Qar province- Iraq [PDF]

Journal of Bioscience and Applied Research
"Any chronic or acute problem in the kidneys or heart which can lead to a chronic or acute problem of the other" is known as "cardiorenal syndrome" (CRS).
Hadeel Faraj
doaj   +1 more source

Plasma homocysteine and cardiovascular risk in heart failure with and without cardiorenal syndrome

, 2010
Plasma homocysteine (Hcy) has been associated with an increased cardiovascular (CV) risk in patients with chronic heart failure (CHF). Thus, we investigated whether Hcy has a prognostic impact on CV events in CHF-patients with and without cardiorenal ...
Burri, Sonja, Hess, Otto M., Hullin, Roger, Martinelli, Michele, Mohacsi, Paul, Maurer, Michaela, de Marchi, Stefano   +6 more
core   +1 more source

Early Dapagliflozin and Melatonin Treatment Ameliorated LV Fibrosis via Suppressing TGF‐β1/Smads and Activating Nrf2‐ARE Signaling in MI Rodent

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT This study tested whether combined dapagliflozin (DAPA) and melatonin (Mel) therapy was superior to merely one for ameliorating the left ventricular (LV) fibrosis/remodeling and improving LV ejection fraction (LVEF) in rats after acute myocardial infarction (AMI). In vitro study demonstrated that DAPA treatment significantly suppressed the TGF‐
Jiunn‐Jye Sheu, Jui‐Ning Yeh, Han‐Tan Chai, John Y. Chiang, Chi‐Ruei Huang, Jun Guo, Hon‐Kan Yip   +6 more
wiley   +1 more source

The cardiorenal syndrome

SA Heart Journal, 2017
The progress made in the medical and device therapy of chronic heart failure (CHF) due to left ventricular systolic dysfunction has heralded new problems.
Eric Klug
doaj   +1 more source

Renal‐vascular axis: unmasking its role in vascular endothelial growth factor‐inhibitor vascular toxicity in cancer patients

British Journal of Pharmacology, EarlyView.
Abstract Vascular toxicity is a growing concern in cancer patients receiving vascular endothelial growth factor inhibitor (VEGFi) therapy, posing a significant threat to patient prognosis. While the primary mechanism of VEGFi‐induced vascular toxicity is linked to redox‐sensitive reactions that disrupt vascular tone, leading to hypertension and ...
Grace Whelan, Karla B. Neves
wiley   +1 more source

Clinical and instrumental features of cardiorenal syndrome in cats with hypertrophic cardiomyopathy

RUDN Journal of Agronomy and Animal Industries
This research presents novel insights into the temporal dynamics of clinical and instrumental parameters pertaining to the emergence of cardiorenal syndrome in feline patients afflicted with hypertrophic cardiomyopathy.
Varvara M. Byakhova, Olesya A. Petrukhina, Elena A. Notina, Irina A. Bykova   +3 more
doaj   +1 more source